Annual Shareholders Equity
$510.61 M
+$202.78 M+65.87%
December 1, 2024
Summary
- As of March 10, 2025, FDMT annual stockholders equity is $510.61 million, with the most recent change of +$202.78 million (+65.87%) on December 1, 2024.
- During the last 3 years, FDMT annual shareholders equity has risen by +$191.50 million (+60.01%).
- FDMT annual shareholders equity is now at all-time high.
Performance
FDMT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$510.61 M
-$42.34 M-7.66%
December 1, 2024
Summary
- As of March 10, 2025, FDMT quarterly stockholders equity is $510.61 million, with the most recent change of -$42.34 million (-7.66%) on December 1, 2024.
- Over the past year, FDMT quarterly shareholders equity has stayed the same.
- FDMT quarterly shareholders equity is now -14.98% below its all-time high of $600.56 million, reached on March 31, 2024.
Performance
FDMT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
FDMT Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +65.9% | 0.0% |
| 3 y3 years | +60.0% | +54.8% |
| 5 y5 years | +799.8% | +54.8% |
FDMT Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +120.7% | -15.0% | +133.6% |
| 5 y | 5-year | at high | +799.8% | -15.0% | +799.8% |
| alltime | all time | at high | +799.8% | -15.0% | +799.8% |
4D Molecular Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $510.61 M(+65.9%) | $510.61 M(-7.7%) |
| Sep 2024 | - | $552.95 M(-6.0%) |
| Jun 2024 | - | $588.34 M(-2.0%) |
| Mar 2024 | - | $600.56 M(+95.1%) |
| Dec 2023 | $307.83 M(+33.1%) | $307.83 M(-6.7%) |
| Sep 2023 | - | $329.93 M(+1.5%) |
| Jun 2023 | - | $325.14 M(+48.7%) |
| Mar 2023 | - | $218.61 M(-5.5%) |
| Dec 2022 | $231.34 M | $231.34 M(-8.0%) |
| Sep 2022 | - | $251.44 M(-7.7%) |
| Jun 2022 | - | $272.52 M(-8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $296.06 M(-7.2%) |
| Dec 2021 | $319.11 M(+24.5%) | $319.11 M(+42.4%) |
| Sep 2021 | - | $224.13 M(-6.9%) |
| Jun 2021 | - | $240.65 M(-0.7%) |
| Mar 2021 | - | $242.43 M(-5.4%) |
| Dec 2020 | $256.39 M(-451.4%) | $256.39 M(+265.5%) |
| Sep 2020 | - | $70.16 M(-196.1%) |
| Dec 2019 | -$72.97 M(+164.5%) | -$72.97 M(+72.5%) |
| Jun 2019 | - | -$42.30 M(+53.3%) |
| Dec 2018 | -$27.59 M(+40.8%) | -$27.59 M |
| Dec 2017 | -$19.59 M | - |
FAQ
- What is 4D Molecular Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual shareholders equity year-on-year change?
- What is 4D Molecular Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly shareholders equity year-on-year change?
What is 4D Molecular Therapeutics annual stockholders equity?
The current annual shareholders equity of FDMT is $510.61 M
What is the all time high annual shareholders equity for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual stockholders equity is $510.61 M
What is 4D Molecular Therapeutics annual shareholders equity year-on-year change?
Over the past year, FDMT annual stockholders equity has changed by +$202.78 M (+65.87%)
What is 4D Molecular Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of FDMT is $510.61 M
What is the all time high quarterly shareholders equity for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly stockholders equity is $600.56 M
What is 4D Molecular Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, FDMT quarterly stockholders equity has changed by $0.00 (0.00%)